A detailed history of Mariner, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Mariner, LLC holds 27,085 shares of EXAS stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,085
Previous 31,586 14.25%
Holding current value
$1.56 Million
Previous $1.33 Million 38.23%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.43 - $70.83 $190,977 - $318,805
-4,501 Reduced 14.25%
27,085 $1.84 Million
Q2 2024

Aug 13, 2024

SELL
$41.33 - $74.26 $73,856 - $132,702
-1,787 Reduced 5.35%
31,586 $1.33 Million
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $133,303 - $174,761
-2,369 Reduced 6.63%
33,373 $2.3 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $58,587 - $75,114
-992 Reduced 2.7%
35,742 $2.64 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $304,049 - $456,673
4,611 Added 14.35%
36,734 $2.51 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $169,486 - $257,015
2,704 Added 9.19%
32,123 $3.02 Million
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $13,543 - $20,310
287 Added 0.99%
29,419 $1.99 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $153,115 - $268,141
-5,045 Reduced 14.76%
29,132 $1.44 Million
Q3 2022

Nov 10, 2022

SELL
$31.97 - $49.37 $21,451 - $33,127
-671 Reduced 1.93%
34,177 $1.11 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $39,811 - $85,225
1,118 Added 3.31%
34,848 $1.37 Million
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $3,914 - $5,612
68 Added 0.2%
33,730 $2.36 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $653,515 - $907,529
-9,014 Reduced 21.12%
33,662 $2.62 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $1.49 Million - $2.05 Million
16,537 Added 63.27%
42,676 $4.07 Million
Q2 2021

Aug 24, 2021

BUY
$93.66 - $139.27 $74,834 - $111,276
799 Added 3.15%
26,139 $3.25 Million
Q1 2021

May 07, 2021

BUY
$116.57 - $155.01 $1.54 Million - $2.05 Million
13,208 Added 108.87%
25,340 $3.34 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $6,972 - $9,948
70 Added 0.58%
12,132 $1.61 Million
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $108,140 - $151,280
-1,483 Reduced 10.95%
12,062 $1.23 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $755,133 - $1.26 Million
13,545 New
13,545 $1.18 Million
Q3 2019

Nov 13, 2019

SELL
$90.37 - $122.49 $517,187 - $701,010
-5,723 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $61,135 - $80,621
683 Added 13.55%
5,723 $676,000
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $28,262 - $44,004
-456 Reduced 8.3%
5,040 $437,000
Q4 2018

Feb 13, 2019

BUY
$56.04 - $82.66 $307,995 - $454,299
5,496 New
5,496 $347,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.